Icotrokinra is a first-in-class investigational targeted oral peptide that selectively blocks the IL-23 receptor 1 Filing ...
Weekly roundup of important topics to help you in your Prelims and Mains preparation. Here are the key news highlights from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback